John P. Moore
7Patents
4h-index
19Co-inventors
50Inventor score
Filing activity: Jun 23, 2000 → Mar 9, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7939083B2 | Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain | Chemistry; Metallurgy | 40 | Active |
| US7592014B2 | Stabilized viral envelope proteins and uses thereof | Chemistry; Metallurgy | 29 | Active |
| US7022324B2 | Stabilized viral envelope proteins and uses thereof | Chemistry; Metallurgy | 15 | Expired |
| US6710173B1 | Stabilized viral envelope proteins and uses thereof | Chemistry; Metallurgy | 15 | Expired |
| US9738688B2 | HIV-1 envelope glycoprotein | Chemistry; Metallurgy | 4 | Active |
| US7479553B2 | Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteins | Chemistry; Metallurgy | 1 | Expired |
| US10106583B2 | Materials and methods for producing cleaved, HIV-1 envelope glycoprotein trimers | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.